Crinetics Pharmaceuticals Inc (CRNX)
R&D to Revenue
397.52%
Quarterly · Period ending:
CRNX R&D to Revenue
Latest reported397.52%period ending
Latest reported397.52%period ending
CRNX Quarterly R&D/Revenue (0.00% → 397.52%)
Latest values, visible window
High-resolution chart · PNG
CRNX r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 397.5237% | |
| 932.3738% | |
| 1,380.5064% | |
| 63,261.5385% | |
| 7,788.6518% | |
| 21,119.1136% | |
| 0% | |
| 0% | |
| 14,622.5564% | |
| 8,334.5313% | |
| 0% | |
| 12,670.2312% | |
| 4,113.3603% | |
| 1,435.9089% | |
| 5,217.3484% | |
| 6,984.0611% | |
| 7,515.9453% | |
| 902.3315% | |
| 2,282.3748% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |